Key result
Standardized questionnaires effectively capture quality-of-life drivers in adults with congenital heart disease.
Why the study?
Advances in medical treatments have increased life expectancy in adults with congenital heart disease, raising questions about quality of life and its determinants.
Standardized and validated questionnaires facilitate the measurement of factors influencing quality of life in adults with congenital heart disease.
Advances in medical treatments for adults with congenital heart disease (ACHD) has resulted in reduced mortality, i.e., an increase in patients’ life expectancy. Consequentially, questions concerning quality of life (QoL) and its determinants paralleled this medical progress. The development of standardized and validated questionnaires facilitates the measurement of factors differentially influencing QoL.
No takes yet. Share an insight, caveat, or question.
Kahl et al. (2016) conducted a review in Congenital heart disease. Standardized and validated questionnaires facilitate the measurement of factors influencing quality of life in adults with congenital heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: